Today’s #covid19 headlines:

Medical staff working on covid-19 wards using FFP3 respirators instead of surgical masks have up to 100 per cent protection against infection, a hospital in Cambridge has found. bbc.co.uk/news/health-57…
Brisbane and Perth have joined Sydney and Darwin in imposing lockdowns aiming to contain outbreaks of the delta variant in Australia, which now total about 150 cases. theguardian.com/australia-news…
Indonesia's covid-19 surge is on the edge of a "catastrophe" as the more infectious delta variant dominates transmission and chokes hospitals in southeast Asia's worst epidemic, the Red Cross has said. reuters.com/world/asia-pac…
The vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect against the coronavirus for years, according to research published in Nature. nytimes.com/2021/06/28/hea…
Read our daily #covid19 summary for more updates newscientist.com/article/223747…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with New Scientist

New Scientist Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @newscientist

28 Jun
While global figures vary, it is thought that about 14 per cent of people who catch covid-19 end up with lasting symptoms – which is some 25 million people worldwide. For some, symptoms have persisted for over a year. #LongCovid
One puzzling feature is that those most prone to #LongCovid aren’t those most likely to get sick from the initial infection. Women are 30 per cent more likely to get it than men, and 35 to 69-year-olds are the age group most often affected, according to the @ONS.
One report suggests people with #LongCovid can be divided into four groups: those experiencing the after-effects of ventilation in intensive care; those with organ damage caused by the virus; those with post-viral fatigue syndrome; and a miscellaneous group with varying symptoms.
Read 4 tweets
18 May
Today’s #COVID19 headlines:

The Pfizer/BioNTech covid-19 vaccine can be stored at fridge temperature for up to a month, the European Medicines Agency has said, rather than just five days as previously recommended. bbc.co.uk/news/world-eur…
More than 90 per cent of people develop antibodies to the coronavirus after having one dose of the AstraZeneca or Pfizer vaccines, and almost 100 per cent do so after their second jab, a UK study has found. theguardian.com/world/2021/may…
The US will send an additional 20 million covid-19 vaccines to other countries by the end of June, President Joe Biden has announced, including for the first time vaccines that have been approved for use in the US. nbcnews.com/politics/white…
Read 5 tweets
17 May
All life on Earth depends on nitrogen, but because of human activity, the nitrogen cycle is now dangerously out of whack. Here are five ways that nitrogen pollution is harming our planet. (Thread...) Image
1. Rain can wash nitrates into watercourses and oceans. This nitrogen-based pollution feeds algal blooms that suck up oxygen as they decompose, choking aquatic life. Image
2. Cars and power plants emit nitrogen oxides, which are one of the principal precursors to a type of air pollution called particulate matter. These tiny particles can be breathed into our lungs, where they cause tissue damage associated with a range of health problems. Image
Read 7 tweets
17 May
Today’s #covid19 headlines:

Some restrictions on socialising indoors have been lifted today in England, Wales and most of Scotland, allowing hospitality and entertainment venues to reopen. The prime minister urged people to be cautious. news.sky.com/story/pm-urges…
Covax, the international scheme to support equitable access to covid-19 vaccines, is 140 million doses short because of India's covid-19 crisis, which led to the suspension of vaccine exports in March. bbc.co.uk/news/world-571…
Sanofi and GlaxoSmithKline’s experimental covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials. The companies said they plan to begin late-stage trials and production in the coming weeks. apnews.com/article/europe…
Read 4 tweets
13 May
Today’s #COVID19 headlines:

Evidence is growing that a troubling variant of the coronavirus discovered in India is more transmissible than the variant that is currently dominant in the UK. Cases linked to the variant have tripled in a week in England. theguardian.com/world/2021/may…
Adults are more likely to report mild and moderate side-effects after having a different covid-19 vaccine for their second dose to their first, according to a UK study looking at the Pfizer and AstraZeneca vaccines. bbc.co.uk/news/health-57…
Delaying second vaccine doses for people younger than 65 to prioritise people getting their first dose could lead to fewer people dying of covid-19, according to a modelling study. reuters.com/business/healt…
Read 5 tweets
11 May
Today’s #COVID19 headlines:

The coronavirus variant B.1.617.2, first identified in India, appears to be spread at last as easily as the “Kent variant” that now dominates UK infections, according to analysis by Public Health England. newscientist.com/article/227715…
The next stage of England’s path out of lockdown will go ahead next Monday, the prime minister has confirmed, allowing pubs and restaurants to serve customers inside and university students to return to in-person teaching. theguardian.com/world/2021/may…
US regulators have given approval to expand the use of the Pfizer/BioNTech covid-19 vaccine to children as young as 12. A federal vaccine advisory committee is expected to issue recommendations for using the vaccine in 12- to 15-year-olds tomorrow.
apnews.com/article/corona…
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(